Announcements Trials
Browse Landscape

Phase

Phase 1 20Phase 2 10Phase 1/2 5Phase EARLY_PHASE1 2Phase 2/3 2Phase NA 1Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Breast Neoplasms 1052Neoplasms 886Prostatic Neoplasms 505Lung Neoplasms 422Colorectal Neoplasms 350Motor Activity 221Head and Neck Neoplasms 191Uterine Cervical Neoplasms 186Carcinoma, Non-Small-Cell Lung 180Brain Neoplasms 168Pancreatic Neoplasms 162Ovarian Neoplasms 139Colonic Neoplasms 138Carcinoma, Hepatocellular 134Anxiety Disorders 124Rectal Neoplasms 118Hematologic Neoplasms 114Multiple Myeloma 107Stomach Neoplasms 102Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 96Melanoma 92Depression 92Urinary Bladder Neoplasms 88Pain 88Endometrial Neoplasms 85Lymphoma 83Disease 83Glioblastoma 79Gastrointestinal Neoplasms 78

Interventions

Perfusion Magnetic Resonance Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Gliosarcoma × 1 year × Clear all
NCT03115333 2026-05-06

DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma

Eastern Cooperative Oncology Group

Phase NA Active not recruiting
146 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡